CEACAM5 and colorectal carcinoma: In order to improve sensitivity and specificity required for extensive population screening for diagnosis of early-stage CRC, some authors propose the use of cfDNA concentration in a combination with protein biomarkers, such as carcinoembryonic antigen (CEA) [33].